Blueprint Medicines Aktie
91,10
EUR
+13,02
EUR
+16,68
%
104,72
USD
+5,40
USD
+5,44
%
Werbung
Blueprint Medicines Aktie Analyse
18.07.19 | Blueprint Medicines Buy | Deutsche Bank AG | |
29.09.17 | Blueprint Medicines Buy | BTIG Research | |
05.04.17 | Blueprint Medicines Outperform | Wedbush Morgan Securities Inc. |
Werbung
Werbung